Atlas Growers Investors
Atlas Growers Ltd. is a wholly owned subsidiary of Atlas Biotechnologies Inc. (collectively together “Atlas”) and was established in 2015 with the objective of being an industry leading producer of cannabis products for medical use.
Atlas holds a 160-acre land site north-west of Edmonton, Alberta, where our 38,000 square foot, state-of-the-art, custom designed indoor cultivation facility was completed in September 2018. This initial facility is expected to have production capacity of at least 5,000 kg per year of dried cannabis flower and related oil extracts.
Atlas received its initial Cultivation License from Health Canada under the predecessor ACMPR (Access to Cannabis for Medical Purposes Regulations) on October 12, 2018 and a “Business to Business” Sales License on November 15, 2018. Our initial crop was planted in late December 2018.
IT'S A GROWING MARKET
Legalized sales of recreational cannabis is expected to bolster the entire market. In the first few years of recreational sales, the market value is expected to grow rapidly.
STATS ON CANNABIS USE
of Canadian adults consume recreational cannabis occasionally.
of Canadian adults consume cannabis daily (not including for medical uses).
TOTAL CANADIAN MARKETPLACE
40% OF THE ADULT POPULATION
show willingness to try cannabis now that it is legalized.
THE RESULTS OF RECREATIONAL CANNABIS LEGALIZATION IN COLORADO (2015)
Colorado's population was:
Cannabis sales(after legalization):
Over 18,000 jobs were created in the
THE CANNABIS INDUSTRY BECAME THE FASTEST GROWING BUSINESS SECTOR IN COLORADO
The Atlas Growers Facility
Atlas Growers has developed a purpose-built controlled-environment agricultural facility and laboratory just outside of Edmonton, Alberta. It is a state-of-the-art, 38,000 SQ FT building with nine climate-controlled environments allowing us to create customizable ecosystems for maximum efficiency and minimize risk to crops.
JOIN THE FUTURE OF CANNABIS RESEARCH IN CANADA
We are seeking to make breakthroughs in cannabis production and research. Atlas will be a leader in cannabis genetic breeding programs, pushing the limits of cannabinoid exploration and terpene profile development.